Oral administration of dehydroepiandrosterone-sulfate (DHEAS) increases in vitro lymphocyte function and improves in vivo response of pigs to immunization against keyhole limpet hemocyanin (KLH) and ovalbumin.
The present study tested the hypothesis that the oral administration of DHEAS enhances the in vitro and the in vivo immune response of young pigs. Crossbred, female pigs (80 days of age; 49+/-2 kg) were separated into two treatment groups (n=4/treatment) receiving either 0mg/kg (control) or 1mg/kg DHEAS twice daily (DHEAS) for 5 weeks. On day 7 pigs were immunized against KLH and ovalbumin. Body weight increased weekly throughout the study but did not differ between treatment groups. While white blood cell counts increased in response to immunization but did not differ between treatments, the neutrophil:lymphocyte ratio was enhanced (P<0.05) in DHEAS-supplemented pigs. Concanavalin A (ConA) induced an in vitro dose-dependent increase (P<0.05) in lymphocyte proliferation, but treatment did not affect proliferation prior to immunization. However, lymphocytes isolated from DHEAS-supplemented pigs displayed a greater increase in proliferation following immunization relative to control pigs (P<0.05). Dexamethasone (DEX) attenuated ConA-induced lymphocyte proliferation, with DHEAS-supplemented pigs retaining a greater proliferative response relative to control pigs (P<0.05). Serum IgG concentrations and relative concentrations of antigen-specific IgG increased after immunization with maximum values attained at 21 and 28 days for control and DHEAS-supplemented pigs, respectively. The DHEAS-supplemented pigs had greater (P<0.05) concentrations of IgG and relative concentrations of antigen-specific IgG compared to control pigs. Collectively these data suggest DHEAS supplementation increases the responsiveness of young pigs to antigenic challenge, and may be beneficial for improving their immune function.
Burdick
N C
NC
Department of Animal and Wildlife Sciences, Texas A&M University-Kingsville, Kingsville, TX 78363, USA.
Dominguez
J A
JA
Welsh
T H
TH
Laurenz
J C
JC
D000276:Adjuvants, Immunologic; D000284:Administration, Oral; D000818:Animals; D001835:Body Weight; D019314:Dehydroepiandrosterone Sulfate / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D006433:Hemocyanins / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood; D008213:Lymphocyte Activation / Q000187:drug effects*; D010047:Ovalbumin / Q000276:immunology*; D011897:Random Allocation; D013552:Swine; D014611:Vaccination
D000276:Adjuvants, Immunologic; D007074:Immunoglobulin G; D019314:Dehydroepiandrosterone Sulfate; D003907:Dexamethasone; D010047:Ovalbumin; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin